Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 24134957)

1.

Overexpression of steroid receptor coactivator-3 in bone cancers: an in vivo immunohistochemical study with tissue microarray.

Luo F, Li W, Zhang J, Huang K, Fu J, Xie Z.

Pathol Res Pract. 2013 Dec;209(12):790-6. doi: 10.1016/j.prp.2013.09.008. Epub 2013 Sep 26.

PMID:
24134957
2.

Sustained expression of steroid receptor coactivator SRC-2/TIF-2 is associated with better prognosis in malignant pleural mesothelioma.

Jennings CJ, O'Grady A, Cummins R, Murer B, Al-Alawi M, Madden SF, Mutti L, Harvey BJ, Thomas W, Kay EW.

J Thorac Oncol. 2012 Jan;7(1):243-8. doi: 10.1097/JTO.0b013e31822f6544.

PMID:
22011668
3.

Overexpression and gender-specific differences of SRC-3 (SRC-3/AIB1) immunoreactivity in human non-small cell lung cancer: an in vivo study.

Wang H, Zhang D, Wu W, Zhang J, Guo D, Wang Q, Jing T, Xu C, Bian X, Yang K.

J Histochem Cytochem. 2010 Dec;58(12):1121-7. doi: 10.1369/jhc.2010.956979. Epub 2010 Sep 17.

4.

SRC-3 has a role in cancer other than as a nuclear receptor coactivator.

Ma G, Ren Y, Wang K, He J.

Int J Biol Sci. 2011;7(5):664-72. Epub 2011 May 24. Review.

5.

Expression of estrogen receptors, androgen receptor and steroid receptor coactivator-3 is negatively correlated to the differentiation of astrocytic tumors.

Liu C, Zhang Y, Zhang K, Bian C, Zhao Y, Zhang J.

Cancer Epidemiol. 2014 Jun;38(3):291-7. doi: 10.1016/j.canep.2014.03.001. Epub 2014 Mar 27.

PMID:
24680642
6.

Immunohistochemical localization of steroid receptor coactivators in chondrosarcoma: an in vivo tissue microarray study.

Li W, Fu J, Bian C, Zhang J, Xie Z.

Pathol Res Pract. 2014 Dec;210(12):1005-10. doi: 10.1016/j.prp.2014.04.012. Epub 2014 May 4.

PMID:
24875297
7.

Up-regulation of nuclear receptor coactivator amplified in breast cancer-1 in papillary thyroid carcinoma correlates with lymph node metastasis.

Liu MY, Guo HP, Hong CQ, Peng HW, Yang XH, Zhang H.

Clin Transl Oncol. 2013 Nov;15(11):947-52. doi: 10.1007/s12094-013-1029-x. Epub 2013 Apr 20.

PMID:
23606350
8.

Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.

Haugan Moi LL, Hauglid Flågeng M, Gandini S, Guerrieri-Gonzaga A, Bonanni B, Lazzeroni M, Gjerde J, Lien EA, DeCensi A, Mellgren G.

Clin Cancer Res. 2010 Apr 1;16(7):2176-86. doi: 10.1158/1078-0432.CCR-09-1859. Epub 2010 Mar 23. Erratum in: Clin Cancer Res. 2010 Oct 15;16(20):5087. De Censi, Andrea [corrected to DeCensi, Andrea].

9.

Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover.

Geng C, He B, Xu L, Barbieri CE, Eedunuri VK, Chew SA, Zimmermann M, Bond R, Shou J, Li C, Blattner M, Lonard DM, Demichelis F, Coarfa C, Rubin MA, Zhou P, O'Malley BW, Mitsiades N.

Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6997-7002. doi: 10.1073/pnas.1304502110. Epub 2013 Apr 4.

10.

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

BMC Cancer. 2009 Apr 1;9:102. doi: 10.1186/1471-2407-9-102.

11.

Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.

Balmer NN, Richer JK, Spoelstra NS, Torkko KC, Lyle PL, Singh M.

Mod Pathol. 2006 Dec;19(12):1593-605. Epub 2006 Sep 15.

12.

Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.

Kobayashi T, Tsuda H, Moriya T, Yamasaki T, Kikuchi R, Ueda S, Omata J, Yamamoto J, Matsubara O.

Breast Cancer Res Treat. 2010 Oct;123(3):733-45. doi: 10.1007/s10549-009-0672-y. Epub 2009 Dec 18.

PMID:
20020198
13.

c-Src expression is predictive of poor prognosis in breast cancer patients with bone metastasis, but not in patients with visceral metastasis.

Zhang L, Teng Y, Zhang Y, Liu J, Xu L, Qu J, Hou K, Yang X, Liu Y, Qu X.

APMIS. 2012 Jul;120(7):549-57. doi: 10.1111/j.1600-0463.2011.02864.x. Epub 2012 Jan 23.

PMID:
22716210
14.

SRC-3 coactivator regulates cell resistance to cytotoxic stress via TRAF4-mediated p53 destabilization.

Yi P, Xia W, Wu RC, Lonard DM, Hung MC, O'Malley BW.

Genes Dev. 2013 Feb 1;27(3):274-87. doi: 10.1101/gad.203760.112.

15.

Steroid receptor co-activator-3 promotes osteosarcoma progression through up-regulation of FoxM1.

Geng S, Wang X, Xu X, Zhang H, Ma Y, Zhang Y, Li B, Bi Z, Yang C.

Tumour Biol. 2014 Apr;35(4):3087-94. doi: 10.1007/s13277-013-1406-7. Epub 2013 Nov 27.

PMID:
24282087
16.

Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.

Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl PO, Hedenfalk I.

Breast Cancer Res Treat. 2010 Jul;122(2):315-24. doi: 10.1007/s10549-009-0568-x. Epub 2009 Oct 1.

PMID:
19795205
17.

The steroid receptor coactivator-3 is required for the development of castration-resistant prostate cancer.

Tien JC, Liu Z, Liao L, Wang F, Xu Y, Wu YL, Zhou N, Ittmann M, Xu J.

Cancer Res. 2013 Jul 1;73(13):3997-4008. doi: 10.1158/0008-5472.CAN-12-3929. Epub 2013 May 6.

18.

Differential CARM1 expression in prostate and colorectal cancers.

Kim YR, Lee BK, Park RY, Nguyen NT, Bae JA, Kwon DD, Jung C.

BMC Cancer. 2010 May 13;10:197. doi: 10.1186/1471-2407-10-197.

20.

The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease.

Gojis O, Rudraraju B, Alifrangis C, Krell J, Libalova P, Palmieri C.

Eur J Surg Oncol. 2010 Mar;36(3):224-9. doi: 10.1016/j.ejso.2009.08.002. Epub 2009 Aug 28. Review.

PMID:
19716257
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk